INDICATIONS AND USAGE

» Newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase

» Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including Imatinib Mesylate

» Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment